Skip to content

Comparison of IOL Formulas in Eyes With PCE≥15µm

Intraocular Lens Power Calculation Formulas in Eyes With Posterior Corneal Elevation ≥15 µm: An Eyetemis-based Comparative Analysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07346456
Enrollment
102
Registered
2026-01-16
Start date
2025-04-01
Completion date
2025-09-20
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Comparison of IOL Formulas in Eyes With PCE≥15um Undergoing Cataract Surgery

Keywords

IOL formulas, posterior corneal elevation, refractive outcomes

Brief summary

The goal of this observational study is to evaluate the long-term refractive outcomes of advanced intraocular lens (IOL) power calculation formulas in cataract patients with posterior corneal elevation (PCE ≥ 15 μm). The main question it aims to answer is: Do PK-based formulas provide superior refractive accuracy compared with Without-PK-based formulas in patients with elevated posterior corneal surfaces? Participants undergoing routine cataract surgery will have their biometry measured by both Pentacam AXL and IOLMaster 700, and postoperative refraction will be collected at 1 month, 3 months, and 6 months postoperatively.

Interventions

OTHERIntraocular lens calculation formulas

The study evaluates four groups of intraocular lens (IOL) power calculation formulas, totaling 13 distinct formulas, to compare their accuracy in predicting postoperative refractive outcomes in cataract patients. Group 1 - Without PK: Barrett Universal II (BUⅡ), EVO 2.0, Kane, Hill-RBF 3.0, LADAS, Pearl-DGS, and K6, which do not incorporate PK. Group 2 - Measured PK-I: Barrett TK measured (I) and EVO Advanced (I), which use measured PK from IOLMaster 700. Group 3 - Measured PK-P: Barrett TK measured (P) and EVO Advanced (P), which use measured PK from Pentacam AXL. Group 4 - Predicted PK: Barrett TK predicted and Kane KC, which estimate PK through prediction algorithms rather than direct measurement. This observational study does not introduce experimental procedures; all data are collected during routine cataract surgery and postoperative follow-up to determine the comparative accuracy of these formulas

Sponsors

Second Affiliated Hospital of Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Meeting the indications for cataract surgery, and undergoing Phacoemulsification + IOL implantation performed by the same surgeon. * Preoperative biometry performed with IOLMaster 700 and Pentacam AXL, with a posterior corneal elevation greater than 15 μm within the central 5 mm zone on Scheimpflug imaging, and a central corneal thickness \> 500 μm. * Surgery completed successfully without any intraoperative or postoperative complications. * Postoperative subjective refraction performed at 1 month after surgery by the same experienced optometrist.

Exclusion criteria

* Patients with pterygium, corneal diseases, glaucoma, uveitis, or fundus diseases (such as macular edema, retinal detachment), excluding high myopia. * History of ocular trauma or previous intraocular surgery. * Occurrence of intraoperative or postoperative complications, such as iris injury, posterior capsule rupture, IOL dislocation, vitreous prolapse, or vitreous hemorrhage. * Postoperative best corrected visual acuity (BCVA) worse than 0.5. * Difference between postoperative subjective refraction and preoperative target refraction greater than 2.00 D. * Incomplete measurement data.

Design outcomes

Primary

MeasureTime frameDescription
absolute SEQ-PE(accuracy)From enrollment to the end of treatment at 6 monthsthe absolute values of SEQ-PE
SEQ-PE(trueness)From enrollment to the end of treatment at 6 monthsSpherical Equivalent Prediction Error 1. SEQ=Sphere+2Cylinder 2. PE=Postoperative Manifest SEQ-Predicted SEQ
PrecisionFrom enrollment to the end of treatment at 6 monthsPrecision refers to the consistency of the prediction errors (PE) of a formula across a study population, indicating how closely the individual prediction errors cluster around the central tendency (e.g., mean or median). A formula with higher precision shows smaller variability in its prediction errors.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026